$85.00
A synthetic 39-amino acid triple receptor agonist targeting GIP, GLP-1, and glucagon pathways. Investigated in preclinical and clinical research settings for its role in metabolic regulation and body composition modulation.
Retatrutide (GLP-3, RT) is a synthetic 39-amino acid triple receptor agonist targeting GIP, GLP-1, and glucagon pathways. Investigated in preclinical and clinical research settings for its role in metabolic regulation and body composition modulation.
Triple receptor agonism studies — GIP, GLP-1, glucagon
Metabolic regulation research in animal models
Body composition modulation studies
Glucose homeostasis pathway investigation
Energy expenditure mechanism research
Lipid metabolism studies in vitro
For laboratory and in-vitro scientific research purposes only. Not for human or animal consumption, therapeutic use, or diagnostic application of any kind.
Join our list for early access, new compounds, and exclusive offers.
No spam. Unsubscribe anytime.
Added to cart
Check out our shop to see what's available